KALA / KALA BIO, Inc. - Net Long/Short Value

KALA BIO, Inc.

KALA / KALA BIO, Inc. - Net Long/Short Value
Auf dieser Seite finden Sie die Netto-Long/Short-Bewertungen für jede institutionelle Beteiligung, die über die 13F- oder NPORT-Berichte gemeldet wurde. Um den Netto-Long/Short-Wert zu berechnen, addieren wir den Aktienwert zum Wert der Call-Option und ziehen den Wert der Put-Option ab. Fonds, die geliehene Short-Positionen melden, weisen den Aktienwert als negativ aus. Netto-Long-Positionen haben positive Zahlen in der Netto-Long/Short-Spalte, und Netto-Short-Positionen haben negative Werte in dieser Spalte.
Besitzer Eigenkapitalwert
($1000)
Call Wert
($1000)
Put Wert
($1000)
Net Long/Short
($1000)
Goldman Sachs Group Inc
Steward Partners Investment Advisory, Llc
State Street Corp
ADAR1 Capital Management, LLC
Vanguard Global Advisers, LLC
Virtu Financial LLC
Morgan Stanley
International Assets Investment Management, Llc
Renaissance Technologies Llc
Motiv8 Investments LLC
UBS Group AG
StoneX Group Inc.
Gsa Capital Partners Llp
Citadel Advisors Llc
Grant Private Wealth Management Inc
Legacy Wealth Managment, LLC/ID
Covestor Ltd
Geode Capital Management, Llc
Jane Street Group, Llc
BlackRock, Inc.
LPL Financial LLC
MAI Capital Management
Vanguard Fiduciary Trust Co
Vanguard Capital Management Llc
Greenwich Wealth Management LLC
Northern Trust Corp
Vanguard Group Inc
SBI Securities Co., Ltd.
Jpmorgan Chase & Co
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
GB:0JQ2 2,42 $
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista